PTIX Protagenic Therapeutics
- 0.6199
- +0.0489+8.56%
- 0.5843
- -0.0356-5.74%
Protagenic Therapeutics News
8-K: Current report
10-Q: Q2 2024 Earnings Report
8-K: Current report
S-3: Registration statement for specified transactions by certain issuers
8-K: Current report
8-K: Current report
10-Q: Q1 2024 Earnings Report
10-K/A: Annual report (Amendment)
10-K/A: Annual report (Amendment)
Protagenic Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director WRIGHT TIMOTHY R
Protagenic Therapeutics | 10-K: FY2023 Annual Report
Protagenic Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Stein Robert Benjamin
Protagenic Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Barrage Khalil
Protagenic Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Buell Jennifer
Protagenic Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer ARMEN GARO H
Protagenic Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Corvese Brian
Protagenic Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Arrow Alexander K.
Protagenic Therapeutics | 8-K: Current report
Protagenic Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Armistice Capital, LLC(5.13%),Steven Boyd(5.13%)
Protagenic Therapeutics | 8-K: Current report
Analysis
Price Target
No Data
No Data